These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7009265)

  • 1. Prevention of diabetic nephropathy by diet control in the db/db mouse.
    Lee SM; Bressler R
    Diabetes; 1981 Feb; 30(2):106-11. PubMed ID: 7009265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db).
    Lee SM; Tutwiler G; Bressler R; Kircher CH
    Diabetes; 1982 Jan; 31(1):12-8. PubMed ID: 6759207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a high fibre diet on diabetic nephropathy in the db/db mouse.
    Lee SM
    Diabetologia; 1982 May; 22(5):349-53. PubMed ID: 6284577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice.
    Teixeira SR; Tappenden KA; Erdman JW
    J Nutr; 2003 Mar; 133(3):673-8. PubMed ID: 12612136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).
    Brouhard BH; Rajaraman S; LaGrone LF
    Int J Pediatr Nephrol; 1987; 8(2):59-68. PubMed ID: 3308729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chronic alpha-glycosidase inhibition on diabetic nephropathy in the db/db mouse.
    Lee SM
    Diabetes; 1982 Mar; 31(3):249-54. PubMed ID: 6759241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
    Arakawa K; Ishihara T; Oku A; Nawano M; Ueta K; Kitamura K; Matsumoto M; Saito A
    Br J Pharmacol; 2001 Jan; 132(2):578-86. PubMed ID: 11159708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciglitazone, a new hypoglycemic agent. 5. Effect on renal lesions in C57BL/KsJ-db/db mice.
    Diani AR; Peterson T; Sawada G; Jodelis K; Wyse BM; Gilchrist BJ; Hearron AE; Chang AY
    Nephron; 1986; 42(1):72-7. PubMed ID: 3941752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the glomerular mesangium and the juxtaglomerular apparatus in the genetically diabetic mouse.
    Bower G; Brown DM; Steffes MW; Vernier RL; Mauer SM
    Lab Invest; 1980 Oct; 43(4):333-41. PubMed ID: 7003252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-protein diet improves blood and urinary glucose levels and renal manifestations of diabetes in C57BLKS-db/db mice.
    Arimura E; Horiuchi M; Kawaguchi H; Miyoshi N; Aoyama K; Takeuchi T
    Eur J Nutr; 2013 Mar; 52(2):813-24. PubMed ID: 22692501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.
    Chen S; Iglesias-de la Cruz MC; Jim B; Hong SW; Isono M; Ziyadeh FN
    Biochem Biophys Res Commun; 2003 Jan; 300(1):16-22. PubMed ID: 12480514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.
    Hofmann SM; Dong HJ; Li Z; Cai W; Altomonte J; Thung SN; Zeng F; Fisher EA; Vlassara H
    Diabetes; 2002 Jul; 51(7):2082-9. PubMed ID: 12086936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice.
    Orland MJ; Permutt MA
    Diabetes; 1987 Mar; 36(3):341-7. PubMed ID: 3542656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice.
    Collins SJ; Alexander SL; Lopez-Guisa JM; Cai X; Maruvada R; Chua SC; Zhang G; Okamura DM; Matsuo S; Eddy AA
    Nephron Exp Nephrol; 2006; 104(1):e23-34. PubMed ID: 16735799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of decline in renal function in the diabetic db/db mouse.
    Cohen MP; Clements RS; Cohen JA; Shearman CW
    Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reduced dietary zinc intake on carbohydrate and Zn metabolism in the genetically diabetic mouse (C57BL/KsJ db+/db+).
    Southon S; Kechrid Z; Wright AJ; Fairweather-Tait SJ
    Br J Nutr; 1988 Nov; 60(3):499-507. PubMed ID: 3219321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease in the db/db mouse.
    Sharma K; McCue P; Dunn SR
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1138-44. PubMed ID: 12736165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes.
    Wei P; Lane PH; Lane JT; Padanilam BJ; Sansom SC
    Diabetologia; 2004 Sep; 47(9):1541-9. PubMed ID: 15338127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.